← SynDRA
TRETAZICAR
SynDRA canonical compound SYN0001392 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | NQO2 |
| Mechanism of action | DNA replication inhibitor |
All known targets
Mechanisms of action (all sources)
- DNA replication inhibitor
- NQO2 INHIBITOR
Drug classes
- Antineoplastic Agents
- Radiation-Sensitizing Agents
Cross-references
Synonyms
- CB-1954
- NSC-115829
- CB1954
- 5-(1-Aziridinyl)-2,4-dinitrobenzamide
- 5-Aziridino-2,4-dinitrobenzamide
- 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE
- 5-Aziridinyl-2,4-dinitrobenzamide
- Tretazicar [INN]
- 2,4-Dinitroethyleneiminobenzamide
- 2,4-Dinitro-5-ethyleneiminobenzamide
- CHEMBL23330
- CCRIS 1631
- UNII-7865D5D01M
- NSC 115829
- 7865D5D01M
- BRN 5825582
- Benzamide,5-(1-aziridinyl)-2,4-dinitro-
- Benzamide, 5-(1-aziridinyl)-2,4-dinitro-
- CB1
- C9H8N4O5
- SMR000326847
- aziridine dinitrobenzamide
- CB1954(Tretazicar)
- AC1Q1YAR
- CB 1954
- 5-[aziridin-1-yl]-2,4-dinitrobenzamide
- tretazicarum
- RefChem:190772
- Tretazicar (>94%)
- MFCD00869490
- CB1954; Tretazicar
- CB 1954, solid
- CB1954(Tretazicar)?
- Lopac-C-2235
- Lopac0_000200
- MLS000859988
- MLS001066333
- SCHEMBL366755
- orb1300455
Look up TRETAZICAR in the interactive SynDRA portal →